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Abstract: Increasing interest for the application of polypeptide-based smart systems in the 
biomedical field has developed due to the advantages given by the peptidic sequence. This is due to 
characteristics of these systems, which include: biocompatibility, potential control of degradation, 
capability to provide a rich repertoire of biologically specific interactions, feasibility to self-assemble, 
possibility to combine different functionalities, and capability to give an environmentally responsive 
behavior. Recently, applications concerning the development of these systems are receiving greater 
attention since a targeted and programmable release of drugs (e.g. anti-cancer agents) can be 
achieved. Block copolymers are discussed due to their capability to render differently assembled 
architectures.  Hybrid systems based on silica nanoparticles are also discussed. In both cases, the 
selected systems must be able to undergo fast changes in properties like solubility, shape, and 
dissociation or swelling capabilities. This review is structured in different chapters which explain the 
most recent advances on smart systems depending on the stimuli to which they are sensitive. 
Amphiphilic block copolymers based on polyanionic or polycationic peptides are, for example, 
typically employed for obtaining pH-responsive systems. Elastin-like polypeptides are usually used 
as thermoresponsive polymers, but performance can be increased by using techniques which utilize 
layer-by-layer electrostatic self-assembly.  This approach offers a great potential to create 
multilayered systems, including nanocapsules, with different functionality. Recent strategies 
developed to get redox-, magnetic-, ultrasound-, enzyme-, light- and electric-responsive systems are 
extensively discussed. Finally, some indications concerning the possibilities of multi-responsive 
systems are discussed.  
Keywords: smart polymers; polypeptides; pH responsive; temperature responsive; light responsive; 
magnetic responsive; enzyme responsive; electric responsive; multiresponsive 
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1. Introduction  
Polypeptide-based nanoparticles have an increasing number of applications in nanomedicine 
due to their biodegradability and capability to be sensitive to external stimuli.  For example, 
changes of the environmental pH when amphiphilic peptides are employed. Therapeutic drugs can be 
easily encased into nanoparticles or adsorbed at their surface leading to clear advantages with respect 
to the use of non-encapsulated conventional drugs.  These advantages include: enhanced stability, 
controlled and triggered release when stimuli responsive polymers are involved, increased 
biocompatibility, and improved therapeutic effect since a high amount of drug can reach the target 
site. Different kinds of polypeptide-based nanoparticles can be considered for drug delivery 
applications (Figure 1): nanospheres, dendrimers, nanocapsules, liposomes and polymeric micelles 
(polymersomes).  Block copolymers can be designed to have a great capability to assemble into 
vesicles and hydrogels with unique properties. Most of these may also be a consequence of the 
possibility of blocks to adopt the typical ordered conformations of polypeptides. Furthermore, 
stimulus-responsive functionalities can easily be given, increasing the potential applications in 
medical uses [1]. 
 
Figure 1. Scheme showing the incorporation of drugs in different nanoparticles: a) 
nanocapsules, b) nanospheres, c) liposomes, d) polymeric micelles and e) dendrimers. 
Based on [2].   
Crucho has recently performed an excellent review concerning the design and formulation of 
stimuli-responsive polymeric nanoparticles (NNPs). Factors including: pH, temperature, magnetic 
field, ultrasound, and light can be appropriate stimuli to trigger drug delivery to target cells (Figure 
2). In general, polymers should be able to undergo fast changes in characteristics like shape, 
solubility, swelling, dissociation, and surface [2–6]. 
Development of nanoscale delivery systems has received increasing attention and great progress 
has been made on the targeted delivery of anticancer drugs such as doxorubicin and paclitaxel [7].  
Application of these new systems is still problematic due to different weaknesses that should still be 
improved including [8,9]: a) Difficulty to reach the minimal effective concentration at the target site 
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due to limited drug loading capacity, b) Difficulty to get an appropriate release rate (slow in the 
bloodstream and fast in the targeted cancer cells), c) Low in vivo stability since micelles disintegrate 
as a consequence of their dilution in the bloodstream (i.e. a concentration less than the critical 
micelle concentration is attained).  
 
Figure 2. Scheme showing different stimuli-responsive drug delivery systems for 
treatment of cancer cells. Reproduced with permission from [1] © 2015, Wiley-VCH.  
This review is focused on systems based on polypeptides for exclusive applications in the 
biomedical field. Polypeptides provide different advantages, in addition to those previously indicated, 
like [10]: a) A rich repertoire of biologically specific interactions, b) Environmentally responsive 
behaviors, c) Capability to self-assemble, d) Control over biodegradation routes and e) Possibility to 
combine different functionalities.  
It is also well established that polypeptides can undergo secondary structural changes as a 
response to external stimuli (e.g. temperature, solvent, pH, and surfactant). Initial studies were 
performed with poly(-benzyl-L-glutamate) (PBGL) and poly(L-lysine) taking advantage of the 
capability to undertake a helix-coil transition [11,12,13]. Deprotection of side chains of the PBLG 
may lead to the occurrence of pH dependent conformational transitions. These stimuli responsive 
polypeptides can be attached to the surface of silica beads giving rise to hybrids that could be 
considered similar to protein-caged viruses and even used for therapeutic purposes.   
Soliman et al. have performed a highly interesting review [14] concerning the capability of 
polycations to be associated with oppositely charged nucleic acids (DNA, RNA and oligonucleotides) 
by electrostatic interactions. The condensation process lead the formation of complexes or 
‘‘polyplexes’’ that can be easily transported in biological media and across cell membranes to the 
cytoplasm, giving rise to a great potential for gene and related therapies. 
The impact of polypeptide composite particles (PCPs) based around a silica core has recently 
been reviewed by Rosu et al. [15]. These hybrids have great limitations when being used as 
platforms for targeted applications. 
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Copolymers containing at least one polypeptide block are interesting due to their ability to 
hierarchically assemble into stable ordered structures [16]. Blocks of cationic and anionic 
polypeptides can be combined with biocompatible polyesters and polyethers to form amphiphilic 
copolymers which, in turn, could be self-assembled into aggregates like polymeric vesicles 
(polymersomes), or cylindrical and spherical micelles which are useful for biomedical applications. 
Polymersomes have fluid-filled cores with walls that consist of entangled chains [17], which separate 
the core from the outside environment. The weight fraction and molecular weight of the hydrophilic 
block, and the interaction parameter between the hydrophobic block and water determines the type 
and form of aggregate that could be produced [14]. Tubular polymersomes, for example, are also 
interesting since they have delayed internalization kinetics, long circulation times and excellent 
tumor targeting ability [19,20]. 
Quadir et al. [21] have recently reviewed the efforts focused to the incorporation of substituent 
groups of diverse chemical nature in synthetic polypeptides by means of click chemistry. In this way, 
facile routes to design tunable and responsive polypeptide architectures have been highlighted.   
2. PH-Responsive Polymers Based on Polypeptides 
Extracellular pH is relatively constant (i.e. usually between 7.2 and 7.45) but it can drop as low as 
6.4 in tumors [22,23] since cancer cells can metabolize glucose utilizing a patway that produces  
lactate [24]. This difference is an interesting potential way to induce a selective drug release, but 
obviously materials would need to respond to a very narrow pH range. This is not the case, for the 
intracellular pH which can vary significantly between the different parts (e.g. from 4 to 8) (Figure 3). 
Materials can enter into cells via endocytosis leading to a fast acidification to a pH between 4.5 and 
5.5. Proton pumps and channels of endosomal membranes allow the acidification to occur which 
implies the pumping of counter ions to keep the charge balance and the diffusion of water to maintain 
the osmotic pressure. In any case, acidification can be exploited to activate the release mechanism. 
Most of pH sensitive polymer systems are based on polyelectrolites since they can be ionized 
under the appropriate pH causing the solubilization or an expansion of their typical coiled coil 
conformation [25]. In this way, ionizable groups can be attached to the polymer backbone (e.g. 
peptides having glutamic and aspartic acid residues that become sensitive to low pH values and 
peptides having lysine, histidine and arginine units that are sensitive to basic pHs). Polymers can also 
bear pH-sensitive bonds whose cleavage causes the release of drugs attached to the polymer backbone 
[26]. 
Anionic peptides containing carboxylic groups, such as poly(aspartic acid) (PAA) and 
poly(glutamic acid) (PGA) are widely employed as pH-sensitive polymers. These polymers are 
protonated at low pH and their backbones become relatively hydrophobic, while they are deprotonated 
at neutral or high pH and consequently become hydrophilic [27]. 
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Figure 3. pH values for different cellular microenvironments. Redox potential and 
abundance of enzymes are also indicated since they can be also useful to get triggered 
release systems. Reproduced with permission from [22] © 2015, Wiley.  
Cationic peptides such as polylysine (PLys), polyhistidine (PHis) and polyarginine (PArg) have 
positively charged amino groups on each monomer at low pH. This feature confers a hydrophilic 
character and a unique condensing gene feature for acting as ideal gene carriers [28].  
Amphiphilic copolymers can be obtained from anionic or cationic peptides by joining them with 
hydrophilic polymers such as PEG. As previously indicated, these amphiphilic copolymers can be 
self-assembled into micelles, nanoparticles, and vesicles depending on the final composition. 
Nevertheless, solvent also plays a relevant role since compact vesicles are favoured when the dipole 
moment of the solvent is low. In this case, shrunken, rodlike peptidic helices are packed side-by-side 
along their long axes to form a compact vesicle. 
Amphiphilic copolypeptide systems based on polyleucine and polylysine blocks were able to 
form vesicular membranes and even hydrogel networks [29,30]. Nevertheless, the presence of highly 
charged polypeptide segments (e.g., poly(L-lysine)) distorted the membranes due to repulsive 
polyelectrolite interactions. Therefore, similar diblock copolymers with shorter charged segments (i.e. 
poly(L-lysine)20-80-b-poly(L-leucine)10-30 and poly(L-glutamic acid)60-b-poly(L-leucine)20) were 
studied by Holowka et al. [31] in order to get stable charged polypeptide membranes.  
Assembling of the zwitterionic diblock copolymer of poly(L-glutamic acid) and  poly(L-lysine) 
(PGA-b-PLys) gave rise to reversible polymersomes [32], which self-assembled under both acidic  
(pH < 4) and basic (pH > 10) conditions. At low pH PLGA was protonated causing a decrease in 
solubility and the stabilization of a compact helical (“rod”) structure. The increased hydrophobicity 
drove the self-assembly of polymersomes. PGA formed the core while PLys block exhibited a -sheet 
structure with a good solubility and formed the shell. Under basic conditions, a solubility change was 
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observed as well as a structure reversion which means that PGA and PLys formed the shell and the 
core, respectively.  
PEG–polypeptide copolymers with amine pendant chains have been synthesized by click 
chemistry to generate materials that can be self-assembled as vesicles and used as effective pH 
sensitive drug carriers. Synthesis was carried out by combining typical N-carboxyanhidride ring 
opening polymerization with post-functionalization using azyde-alkyne cycloaddition. Specifically, 
these nanosized vesicles were stable platforms for delivery and could be successfully localized in solid 
tumors to release doxorubicin (DOX) through the enhanced permeability and retention (EPR) effect 
and the lowered pH of the tumor microenvironment [33].  
Amphiphilic AB2 type miktoarm polymers have a greater ability to form vesicles than do typical 
diblock copolymers [34] and furthermore, appear more appropriate to mimic the complex architectures 
of natural phospholipid bilayer vesicles. Taking into account these concepts Yin et al. [35] synthesized 
a histidine-based AB2-miktoarm polymer (mPEG-b-(polyHis)2) that displayed a phospholipid-mimic 
structure, low cytotoxicity, and pH-sensitivity. Below pH 7.4 the polymersome shape changed 
progressively from cylindrical micelles, to spherical micelles, and finally to unimers. The pH decrease 
lead to an increasing hydrophilic weight fraction that could help to disrupt the endosomal membrane 
through proton buffering. Furthermore, this biocompatible histidine-based miktoarm polymer was 
revealed as an appropriate pH-sensitive drug delivery system. 
Several drugs can be loaded into the albumin-based carriers since albumin utilizes different 
binding sites [36]. In addition, albumin shows ideal characteristics like in vivo stability, easy uptake in 
tumor tissues, nonimmugenicity, and nonantigenicity together with absorbability, biodegradability and 
biocompatibility [37,38]. Along these lines, DOX was attached to the bovine serum albumin (BSA) via 
a pH-sensitive linker, cis-aconitic anhydride (CAD), which was able to be hydrolyzed in the acidic 
lysosomal environment and to provide a pH-responsive release of the anti-cancer agent. Folic acid 
(FA) was also linked to albumin in order to increase the selective tumor-targeting ability of the    
conjugate [39]. The selective targeting efficiency of FA is well known since a folate binding protein, 
(i.e. a glycosylphosphatidylinositol [40]) is over-expressed in human tumors (e.g. ovary, uterus, brain) 
while has limited expression on normal cells [41].  
Semi-IPN porous networks based on hyaluronic acid (HA) and poly(aspartic acid) (PAS) have 
recently been prepared and characterized [42]. Intermolecular interactions between both polymers 
were detected by FTIR as well as the poly(aspartic acid) inclusion into the meshes of the network 
derived from crosslinking of HA with divinyl sulfone (DVS).  The physical links between the 
functional groups of HA and PAS increased the thermal stability, while the presence of PAS into the 
HA gel network gave rise to acidic pH sensitivity and also a high swelling capacity.  
3. Thermally-Responsive Polymers Based on Polypeptides 
A local hyperthermia may lead to an aggregation of peptide molecules and the subsequent 
accumulation of these carriers in the tumor vasculature. Peptides dissolve once returned to normal 
temperature giving rise to a high local concentration and extravascular accumulation of the carrier. 
Mild hyperthermia (37–42 ºC) may favor drug delivery into tumor cells since these are more sensitive 
to damage induced by an increase of temperature and vascular permeability in such a way that the 
anti-tumor effect becomes enhanced. 
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The most widely studied thermally responsive peptides are leucine zippers, elastin-like 
polypeptides (ELPs), collagen, and silk [43,44].  
Leucine zippers are involved in the dimerization of several transcription factors [45] and 
correspond to coil intertwining of helices with a characteristic seven-residue repeat sequence [46]. 
These zippers are stable at low temperature but can dissociate at a determined temperature that can 
be controlled by means of the specific peptide sequence. In this way, different thermoresponsive 
systems for drug delivery have been proposed, including systems that take advantage of the capacity 
to prepare switchable hydrogels [47]. Leucine zipper peptides have successfully been incorporated 
into lipid bilayers during liposome preparation, giving rise to hybrids able to deliver high levels of 
anti-cancer drugs like DOX after localized mild hyperthermia [48] (Figure 4). 
Advanced functional hydrogels can be prepared from BAB triblock copolymers constituted by 
two terminal polypeptide domains characteristic of the coiled-coil motif and a central polyelectrolite 
domain. A reversible gelation was observed under suitable pH and temperature conditions due to the 
balance between the oligomerization of the helical ends and the swelling of the central polyelectrolyte 
domain [49]. 
Silk-elastin-like protein polymers (SELPs) are constituted by a silk-inspired hexapeptide (i.e. 
GAGAGS) and pentapeptide sequences based on silk and elastin, respectively. At high temperatures 
the valine residues of the elastin sequence form intermolecular hydrogen bonds. Therefore, a 
conformational change from an initial hydrophilic random coil to a hydrophobic  related structure 
takes place, and an agglomerated state is derived. This thermally reversible process has been integrated 
into plasmonic gold nanostructures that can lead to optically responsive materials [50]. Amino acid 
repeats of [(GVGVP)4(GGGVP)(GVGVP)3(GAGAGS)4] have been prepared by DNA recombinant 
techniques, resulting in a conformational change between 50 and 60 ºC as a result of self-assembly 
behavior and the structural stabilization provided by the β-structure-forming silk-like blocks [51].  
Elastin-like polypeptides can be genetically encoded and consequently, a great control over 
molecular weight and sequence is feasible. The first one is meaningful since it can control 
pharmacokinetics while the second may control the biodegradation and can be designed to give  
biological activity such as the targeting to specific cell receptors [52]. 
 
Figure 4. Thermoresponsive liposomes based on the incorporation of a leucine zipper 
sequence for the delivery of anticancer drugs. Reproduced with permission from [48] © 
2012, American Chemical Society.  
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Drug delivery based on polymeric carriers is of great interest in cancer treatment since these 
systems have an EPR effect in solid tumors and consequently display improved pharmacokinetics with 
respect to free drugs [53]. In addition, these polymer-based carriers can enter more efficiently into 
tumor tissues than into normal tissues. Efforts are now focused on endowing a stimuli responsive 
character that allows targeting the polymeric carrier to the tumor [54].  
Raucher et al. have developed a thermally responsive elastin-like polypeptide (ELP) [55,56] that 
has been employed for thermally targeted delivery of anti-cancer drugs as DOX and other therapeutic 
peptides. Basically, ELPs have a phase transition at a temperature (Tt) that depends on polymer 
concentration and polymer hydrophobicity. The polymer is soluble in aqueous media at temperatures 
below Tt and forms aggregates at higher temperatures than Tt. Aggregates can be accumulated and 
consequently the local concentration of the cargo becomes increased.  A great advantage of the 
proposed polypeptide is the capacity to modify the chain length and composition of the pentapeptide 
repeat sequence (Val-Pro-Gly-Xaa-Gly, where Xaa is any amino acid different from proline) since it is 
genetically engineered [57]. ELPs with a Tt slightly higher than the physiological temperature (e.g. 
close to 40 ºC) are ideal to avoid problems related to necrosis of tissue surrounding the heated    
tumor [58], in which vascular permeability is expected to increase as well as the penetration of the ELP 
polypeptide. Chilkoti et al. reviewed up to four applications of ELPs to drug delivery, with the 
mechanisms of such systems designed to take advantage of the relationship between Tt and the body 
temperature [59]. They also pointed out new potential applications such as providing an appropriate 
design to respond to small (<1) pH differences that exists between normal tissue and solid tumors, and 
the larger pH differences that can be found between the cytoplasm and the endo-lysosomal 
compartments within cells.  
The use of ELPs also appears interesting for water insoluble anti-cancer drugs like paclitaxel. An 
ELP (Figure 5) having both thermo- and pH-sensitive responses has currently been developed for 
promoting the intracellular delivery of paclitaxel [60]. This molecule was coupled to the ELP through 
a hydrazine bond that could subsequently be cleaved at the acidic pH of lysosomes and endosomes. In 
addition, the N-terminus of ELP was modified to contain a cell penetrating peptide by 
adsorptive-mediated endocytosis (CPP) [61].  
The local concentration of paclitaxel caused by the aggregation of ELP increased cytotoxicity and 
apoptosis of even resistant breast cancer cell lines. 
Multilayer architectures with nanometric precision with a wide range of electrical, magnetic, and 
optical properties can be prepared using layer-by-layer (LbL) electrostatic self-assembly of charged 
polymers [63-63]. LbL assembly can be achieved by the alternating exposure of a charged substrate to 
solutions of positively and negatively charged electrolites. The multilayered structure stabilized by 
electrostatic forces can also be applied to curved surfaces of sacrificial colloidal particles, which can 
be subsequently removed giving rise to micro- and nanosized capsules (Figure 6). These capsules 
could be sensitive to external stimuli and therefore appear as promising new drug delivery vehicles. 
Furthermore, the external surface of capsules can for example be pegylated to increase their colloidal 
stability [64] or functionalized with ligands for targeting specific cells [65]. 
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Figure 5. Scheme showing ELP coupled with paclitaxel. The delivery requires the 
N-terminal moiety constituted by a synB1 cell penetrating peptide, the thermally 
responsive elastin-like polypeptide and the C-terminal moiety with the paclitaxel. 
Reproduced with permission from [60] © 2012, Springer.  
 
Figure 6. Preparation of polyelectrolyte hollow capsules via LbL assembly of charged 
polymers on colloidal particles. At the end of the deposition process the core is 
selectively removed through the semipermeable polymer shells. Reproduced with 
permission from [63] © 2006, Elsevier.  
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Thermoresponsive multilayer films consisting of ionic elastin-like peptides have been prepared 
via LbL assembly [66]. Peptides containing lysine and glutamic acid units were employed as 
polycation and polyanion, respectively. The application of monodisperse peptides of similar main 
chain and equidistanced charged moieties led to stable films at biologically relevant pHs despite the 
limited number of charged groups. Furthermore, these multilayered films were temperature-responsive 
around the physiological temperature.  
Linear ELPs have limitations derived from their broad-phase transitions and large hysteresis that 
were caused by the strong hydrogen bonding interactions established between their amide groups. 
Therefore, other thermoresponsive polypeptides with different chemical structures or architectures 
have been developed. These systems are mainly based on the interactions that take place in an aqueous 
polymer solution and define the lower critical solution temperature (LCST). Below this temperature 
polymers are soluble, and above the LCST they become increasingly hydrophobic and form 
aggregates. The abrupt change in solubility, which is governed by the free energy of mixing, is a 
response to the variation of temperature. Basically, oligopeptides or polypeptides with 
thermoresponsive properties can be achieved through covalent modifications that allow tuning the 
hydrophilic/hydrophobic    ratio [67].  
Different nonionic functional polypeptides with tunable thermoresponsive properties have been 
prepared by grafting oligo(ethylene glycol) (OEG) chains. Poly(glutamate) having OEG side-units 
were found to be able to adopt ordered secondary structures depending on the length of the OEG  
units [68]. The LCST in aqueous solution of these copolymers could be easily tuned by varying OEG 
length and the ratio of the comonomers. Therefore, the thermoresponsive characteristic of OEG units 
could be retained. Namely OEG units were still able to form hydrogen bonds with water and exhibit 
reversible dehydration and hydration with variation of temperature. 
Poly-L-cysteine having OEG side chains displayed different solubility and secondary structures 
in water depending on the length of the OEG side chain. These nonionic polypeptides displayed 
reversible thermoresponsive properties in water when the number of ethylene glycol units was 
between 3 and 5 [69]. 
Monodispersed oligoprolines decorated covalently with hydrophobic units showed characteristic 
thermoresponsive behavior with fast and sharp phase transitions at certain concentrations [67]. The 
phase transition temperatures were dependent on the shape and location of the hydrophobic units and 
could be tuned via supramolecular host–guest interactions. 
Helical dendronized polyprolines of high molecular weight showed thermally-induced phase 
transitions that were dependent not only on the dendron generation but also on the arrangement of the 
dendrons along the polyproline backbone [70]. Polymers were prepared by attaching OEG dendrons 
onto the main polyproline chains through click reaction (Figure 7). 
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Figure 7. Synthesis and thermoresponsiveness of dendronized polyprolines. Reproduced 
with permission from [70] © 2013, Wiley-VCH.  
Yan et al. [71] have proposed the use of dynamic covalent chemistry (DCC) to get 
thermoresponsive polypeptides with dynamic characteristics. In fact, several polypeptides have found 
applications as receptors, via self-replication and responsive assembly through the use dynamic 
covalent linkages such as acylhydrazone, imine and disulfide [72,73,74]. New thermoresponsive 
polypeptides (Figure 8) were prepared through dynamic imine linkage via reactions of amino moieties 
from poly(L-lysine)s with aldehydes from oligoethylene glycol (OEG)-based dendrons [71]. 
Differences in thermoresponsiveness were attained due to imine dynamic covalent linkages, making it 
possible to tune the phase transition temperatures by varying the ratio of OEG dendrons with different 
hydrophilicity. Interestingly, the attachment of dendrons enhanced the stabilization of the polypeptide 
helical conformation, which in addition could be reversibly switched through thermally induced 
aggregation. 
Gelatin is a typical hydrogel constituted by proteins which shows a thermally induced phase 
transition and has potential applications as a drug delivery system [75]. Advantages of gelatin are its 
biodegradability, biocompatibility and also the capacity to be modified as discussed below. A random 
coil conformation at sol state is found at temperatures higher than 30 ºC, and upon decreasing the 
temperature below 25 °C, the gelatin solution solidifies, and a continuous network is formed by partial 
helix formation [76]. 
Hydrogels composed of gelatin and the diblock copolymer monomethoxy poly(ethylene 
glycol)-b-poly(D,L-lactide) (MPEG-PDLLA) diblock were found to be able to form gels at a narrow 
temperature range between body temperature and room temperature [77]. The incorporation of a 
diblock copolymer, featuring a LCST, into the gelatin hydrogel could modify its thermal behavior 
giving rise to appropriate materials for biomedical uses. 
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Figure 8. Chemical structure of dynamic OEGylated polypeptides based on 
poly(L-lysine) and reversible imine likages provided by reaction of amino and aldehyde 
groups. 
Gelatin is also usually grafted with other polymers that exhibit thermogelation upon heating since 
it is the usual requirement for polymers to be used for biomedical applications. Gelatin grafted with 
poly-N-isopropylacrylamide (pNiPAAm) showed a thermoresponsive character and improved cell 
proliferation when the pNiPAAm:gelatin weight ratio was above 5.8 [78]. A higher gel porosity that 
provided a favorable cell environment occurred at 37 °C. 
The design of polypeptide-based formulations that undergo liquid to hydrogel transitions upon 
change in temperature is receiving increasing attention since these hybrid copolymers can be mixed 
with cells or injected into tissues as liquids, and subsequently transformed into rigid scaffolds or 
depots. Hybrid block copolymers constituted by PEG and a polypeptide have been widely   
considered [79–82] since the formation of a hydrogel by raising the temperature can be achieved by 
both, the dehydration of PEG segments and the arrangement of polypeptide short segments into 
-sheet structures via intermolecular hydrogen bonds. Polypeptides modified with PEG side chains 
have also been described as thermoresponsible hydrogels [83]. 
Nonionic diblock copolypeptide hydrogels materials with highly reversible thermal transitions 
and tunable properties have been prepared by combining hydrophilic 
poly(γ-[2-(2-methoxyethoxy)ethyl]-rac-glutamate) and hydrophobic poly(L-leucine) segments [84]. 
These nonionic and thermoresponsive hydrogels (Figure 9) were found to support the viability of 
suspended mesenchymal stem cells in vitro and were able to dissolve and provide prolonged release of 
both hydrophilic and hydrophobic molecules. 
4. Redox Responsive Polymers Based on Polypeptides 
Bioactive polymersomes fully based on amino acid and carbohydrate building blocks represent a 
new step to mimick natural vesicles. These block copolymers can be easily synthesized; for example 
X: CH2CH3, CH3 
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by a sequential ring-opening polymerization of benzyl-L-glutamate (PBLG) and propargylglycine 
N-carboxyanhydrides followed by a glycosylation using azide-functionalized galactose [85]. The use 
of synthetic polymers was in this case omitted, whereas a fully biocompatible system was derived. 
New copolymers could be self-assembled by nanoprecipitation giving rise to controlled morphologies 
that varied from worm-like micelles to polymersomes depending on the composition and the 
precipitation protocol. The presence of carbohydrates in the surface of the synthesized nanoparticles 
appears highly interesting to promote cell interaction and recognition, whereas the hydrophobic PBLG 
tends to adopt a helical conformation that enhances the formation and stabilization of vesicles [31]. 
 
Figure 9. Thermoresponsive gelation process for copolymers containing blocks of 
hydrophilic poly(-[2-(2-methoxyethoxy)ethyl]-rac-glutamate) and 
poly(γ-[2-(2-methoxyethoxy)ethyl]-L-glutamate-stat-L-leucine). The second block 
becomes completely hydrophobic at temperatures higher than 37 ºC. Note that L-leucine 
always contribute to the hydrophobicity. In aqueous solutions at > 37 °C, the 
hydrophobic thermoresponsive segments associate to form assemblies that give 3D 
hydrogel networks with hydrophilic segments exposed. Reproduced with permission 
from [28] © 2015, American Chemical Society. 
A structure similar to that of a glycoprotein was also reported by Schatz et al. [86] by synthesizing 
copolymers from natural polysaccharides and polypeptides. Specifically, the amphiphilic 
dextran-block-poly(γ-benzyl-L-glutamate) was found to be able to self-assemble into small vesicles 
that could be used as a new generation of drug- and gene-delivery systems with a high affinity for the 
surface glycoproteins of living cells and with high similarity to viral capsids. 
Poly(γ-benzyl-L-glutamate)-block-dextran (PBLG-b-dextran) copolymers were effectively 
crosslinked with 3,3′-dithiodipropionic acid (DPA) giving rise to redox-responsive micelles [87]. The 
reductive environment characteristic of intracellular conditions was able to dissociate the disulfide 
crosslinks into free thiols. DOX as a model anticancer drug was loaded into the shell of the crosslinked 
micelles and an accelerated release in the presence of glutathione (GSH) was observed along with 
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inhibition of cellular proliferation when the intracellular GSH level was increased by an appropriate 
cell treatment. In fact, the presence of GSH is one of the most significant difference between a normal 
tissue and tumor cells. An extensive review concerning the synthesis strategies for preparing drug 
delivery systems based on polymers containing disulfide bonds has been reported by Liu and Liu [88]. 
The triblock copolymer poly(ethylene glycol)-b-poly(L-cysteine)-b-poly(L-phenylalanine) 
(PEG-PCys-PPhe) was able to self-assemble to form micelles in aqueous solutions and to 
self-cross-link (SCL) by the oxidation of thiol groups in the PCys segments [89]. The in vitro drug 
release in response to GSH was also studied. It was found that the cross-linking reduced the drug loss 
in the extracellular environment under reductive conditions (e.g. that provided by GSH), the release 
was accelerated due to the cleavage of disulfide bonds. The glutathione-responsive micelles could be 
easily taken up by cancer cells like HeLa cells, opening a great potential in intracellular drug delivery 
and the treatment of tumors. 
Recently, greater efforts are focused for the delivery of gene-encoding sequences into different 
stem cells types. An efficient system appears to be the formation of DNA complexes with cell 
penetrating peptide ligands that bind receptors expressed on the cell surface. Beloor et al. [90] have 
proposed a 29 amino acid long peptide, RVG, to bind both human embryonic (hESC) and 
mesenchymal (hMSC) stem cells through the nicotinic acetylcholine receptor. Nanoparticles 
incorporating plasmid DNA were subsequently prepared by conjugating RVG to a redox-sensitive 
biodegradable arginine-grafted dendrimer to get an environment-sensitive DNA release and a reduced 
cytotoxicity due to the high polymer degradability.  Redox-sensitivity was a consequence of the 
presence of several internal disulfide bonds in the grafted polymer that could be reduced in the 
glutathione-rich environment of the cytoplasm eliciting effective release of complexed nucleic acids. 
Small interfering RNA (siRNA) can silence disease-causing genes and consequently the use of 
such agents appears to be a promising alternative for cancer treatment despite their low  
bioavailability [91,92] (Figure 10). The net negative charge and relatively large size of synthetic small 
siRNA hindered the capability to cross biological barriers and furthermore their duplexes are quickly 
degraded by serum and intracellular ribonucleases. To avoid these problems Cavalieri et al. [92] 
designed redox-responsive nanoporous poly(ethylene glycol)–poly-L-lysine particles, NPEG–PLLs, 
using mesoporous silica (MS) as sacrificial porous templates [93].   
Basically, MS particles were incubated in a PLL solution and then reacted with PEG–
NHS-disulfide cross-linker. The MS templates were finally dissolved with a buffered solution to 
encapsulate siRNA with a high loading capacity. Bioactive siRNA was effectively released through 
the reduction of disulfide bonds into the cytosol of prostate cancer cells where nanoparticles were 
previously targeted through the anti-apoptotic factor, survivin.  
Reducible copolypeptides (rCPP) composed of two cationic peptide sequences have also been 
used to form polyplexes with ADN. Specifically, a nuclear localization sequence (NLS) derived from 
the SV40 virus was randomly combined via disulfide bonds with histidine-rich peptides (HRP) that 
provided an endosomal buffering capability. The disulfide bonds in the backbone of the rCPP chains 
were cleaved in a reducing environment provided by dithiothreitol. As a result, short cationic HRP and 
NLS peptide residues with lower affinity to the DNA were formed, enhancing the subsequent 
dissociation of polyplexes [94]. 
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Figure 10. Encapsulation of siRNA into NPEG-PLL via mesopourous silica templating. 
Reproduced with permission from [91] © 2015, American Chemical Society.  
5. Magnetic Responsive Polymers Based on Polypeptides 
Magnetizable nanoparticles (e.g., magnetite, iron, iron oxides, copper and nickel) can be 
incorporated into polypeptides as well as in other biodegradable and biocompatible polymers to get 
magnetic-responsive materials for targeting drug delivery, contrast agents in magnetic resonance 
imaging (MRI), magnetic hyperthermia and tissue engineering [95,96,97]. Various techniques have 
been developed for the preparation of the composite magnetic carriers, including the 
nanoprecipitation, solvent diffusion and emulsion-solvent evaporation [98,99]. 
Particles less than about 10–20 nm in diameter render a single magnetic domain, which is 
associated to a uniform magnetization where all the spins are aligned in the same direction, a high 
coercivity (i.e. a large magnetic intensity is required to completely demagnetize the material) and 
superparamagnetic properties [100]. Magnetic particles are frequently used for separation of 
biomolecules because they can be easily extracted from a sample by applying an external magnetic 
field. To this end particles are functionalized with recognition molecules, such as antibodies or single 
stranded DNA. Numerous strategies have been developed to immobilize peptides on nanoparticles 
taking advantage of the chemical versatility of the amino acids and the capability to modify the 
nanoparticle surface chemistry. Peptides can be directly immobilized by physisorption (i.e. by van der 
Waals, electrostatic and hydrophobic interactions) or chemisorption, or indirectly taking advantage of 
a molecular linker layer previously immobilized on the particle surface. 
Biocompatible superparamagnetic iron oxide nanoparticles (SPIONs) can be easily prepared with 
high reproducibility and therefore appear interesting as targeting systems [101]. The surface of these 
particles should be functionalized with both synthetic polymers like PEG to ensure colloidal stability 
and targeting peptidic sequences, a feature that may be problematic in terms of yield and particle 
agglomeration. An alternative based on the incorporation of SPIONs in an amine-functionalized silica 
matrix has been proposed [102] and a fast response to an external magnetic field verified. Coupling of 
peptides on these magnetic NPs was achieved through heterobifunctional PEG, which acted as a 
cross-linker and enhanced colloidal stability, using a microreactor set-up [103] (Figure 11).  
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Magnetic resonance imaging (MRI) is one of the most powerful techniques to get physiological 
and anatomic information of tissues. Developments carried out on hyperpolarized species (i.e. those 
that experienced a physical spin ordering that temporarily enhances nuclear magnetism by several 
orders of magnitude) are allowing overcoming typical limitations related to the lack of sensitivity.  
Lerche et al. [104] have reviewed the most important improvements leading to noninvasive and 
selective observation of macromolecules and small molecular probes with enhanced time resolution 
and sensitivity.  
The nuclear spin of xenon can easily be hyperpolarized, being the unique species that can cross a 
cell membrane passively while keeping more than 90% of its hyperpolarization [105]. The high 
relaxation time of intracellular xenon and the relatively high exchange time between the inner and 
outer cell compartments opened new perspectives for cell characterization and even for targeting of 
cell receptors. In fact, 129Xe NMR spectra of intact cells contain a signal specific to the intracellular 
compartment that could be different to that associated to the external pool. Interesting applications can 
also be derived from the different fluidity between normal and tumor cells [105]. Kotera et al. have 
recently proposed smart bimodal 129Xe NMR-fluorescence probes for tetracysteine tagged proteins in 
order to facilitate the discrimination of signals coming from the out- and in-cell compartments and 
obviously to address intracellular events [106]. 
The design of a new generation of biocompatible peptide-based molecular machines with 
applications in biological systems has recently been proposed by Kwon et al [107]. Application of a 
static magnetic field allowed the alignment of self-assembled molecular architectures of β-peptide 
foldamers [108]. The well-ordered molecular packing of the structured foldamers (named as 
foldectures [109]) showed an amplified anisotropy of the diamagnetic susceptibility and a 
magnetotactic behaviour at the macroscopic scale in a similar way as magnetosomes in bacteria. These 
microorganisms are able to align and actively swim along the geomagnetic field due to the 
nanometer-sized magnetic crystals bound to their cell membrane [110].  
 
Figure 11. Scheme of the synthetic route of amine-functionalized silica coated SPIONs 
(SHMNPs) surface functionalization (a nuclear localization sequence (NLS) and 
integrin-ligand (cRGD)). Reproduced with permission from [103] © 2015, Wiley-VCH.  
6. Ultrasound-responsive polymers based on polypeptides 
Recent studies have demonstrated the efficiency of ultrasounds as a molecular imaging tool and 
specifically for molecular targets associated with different processes such as venous thrombosis, 
angiogenesis and inflammation [111,112,113]. Basically, microbubbles (MBs) comprising a 
hydrophobic gas and a stabilizing shell are produced. Efficiency of MBs as contrast agents depends on 
the gas compressibility, dimensions (usually between 1–6 mm), wall thickness, viscosity and density 
of the bubble shell [114]. Ultrasound parameters such as frequency, intensity, and pulse repetition 
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frequency are also meaningful to favor the inertial cavitation and MBs fragmentation required for 
penetrating leaky tumors [115].  
MBs should have high circulation stability and can be forced to be adhered and broken at the 
specific site to deposit targeted compounds [116,117]. Borden et al. [118] used a peptide ligand buried 
by a polymeric overbrush in order to avoid immunogenic response and made feasible the adhesion to 
specific cells after being released by the application of an ultrasound radiation force (Figure 12).   
Air-filled MBs made of poly lactic acid (PLA) that are trapped by a polymer platform having a 
recognition hexapeptide (i.e. VRPMPLQ) were found highly efficient for detecting malignant regions 
in the colon epithelium [119]. Polymer shelled MBs can also be loaded with drugs [120,121] such as 
DOX and fragmented by exposure to ultrasounds. The generated drug-loaded nanoparticles were 
capable of accumulating within a tumor and providing a sustained release of the drug [115].  
 
Figure 12. Microbubbles with buried ligands can circulate without any immunogenic response to 
the site of interest. Polymer brush shields the ligand from serum components as red (RBCs) and 
white (WBCs) blood cells but the application of an acoustic pulse can expose the ligand to the 
receptor, giving rise to a targeted adhesion. Reproduced with permission from [118] © 2008, 
Elsevier. 
7. Enzyme-Responsive Polymers Based on Polypeptides 
A useful drug release mechanism can be obtained from peptides able to mimic enzyme substrates 
and also to link to the appropriate drug. In this way, enzymes that are overexpressed in cancer tissues 
can be used to activate the release of loaded drugs. Nanocarriers, through 
receptor-mediated-endocytosis, can enter into cells and internalize to lysosomes where under the 
action of enzymes (e.g. cathepsin and metalloproteases) can degrade and deliver the loaded drug. The 
presence of an appropriate peptide sequence between carrier and drug allows for a fast release under 
the action of the target enzyme.  
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It is also possible to administer the enzyme after the injection of the polymer-drug conjugate. The 
enzyme is expected to be accumulate in the tumor tissue due to the EPR effect, in this case a potential 
limitation is the immunogenicity caused by the incorporation of a foreign enzyme [122].  
A functional lipid, which is cleaved by the protease activity of metalloproteinase-2 (MMP-2), was 
designed for the treatment of hepatocellular carcinomas (HCC) [123]. Specifically, the amino group of 
dioleoylphosphatidylethanolamine was linked to a PEGylated peptide (Gly–Pro–Leu–Gly–Ile–Ala–
Gly–Gln), which was an ideal substrate for MMP-2. The uptake by normal hepatocytes of liposomes 
containing the designed molecule on their surface was inhibited by steric hindrance. In addition, PEG 
moieties extended the liposome circulation half-life since their uptake by macrophages was decreased. 
Interestingly, HCC cells were able to cleave the hybrid molecule, allowing a selective recognition of 
liposomes by the appropriate receptors of HCC cells.  
A Gly-Phe-Leu-Gly peptide was linked to the carboxylic acid end groups of a dendrimer, which 
was conjugated to methoxy poly(ethylene glycol) (MPEG) and DOX. The synthesized nanoparticles 
(size ca. 200 nm) had cathepsin B-sensitive drug release properties due to the sensitivity of the peptide 
sequence to the cleavage by the enzyme, and consequently this system appears as a promising vehicle 
for cancer cell targeting due to the over-expression of cathepsin B [124]. 
Hydrogel microparticles based on PEG functionalized with an enzyme-responsive peptide appear 
attractive for treatment of pulmonary diseases. These hydrogels can be synthesized with sizes between 
0.5 and 5 μm to achieve an efficient deep deposition into the lungs [125], and subsequently can be 
swelled to reach larger sizes in order to avoid their uptake by macrophages. The efficient encapsulation 
of three well-differentiated drugs (hydrophobic dexamethasone, hydrophilic methylene blue and a 
protein based drug) has recently been proven along with a release induced by the presence of   
MMP-2 [126]. 
Mesoporous silica nanoparticles (MSNs) are highly employed as controlled delivery systems 
since they have advantages such as large pore volume and surface area, good biocompatibility, tunable 
pore sizes, and numerous reactive hydroxyl groups to made feasible a high drug loading efficiency.  
In any case, it is necessary to prevent a fast drug leakage, by designing, for example, different 
molecular switches [127,128].  
Functionalized mesoporous silica nanoparticles (MSNs) covered with nanovalves such as 
rotaxanes were used to retain drugs in their pores until gatekeepers were removed by an external 
stimuli that could be an enzyme. Cyclodextrin (CD)-based molecules can effectively block the pore of 
MSNs through cleavable intermediate linkages and dissociate to achieve a rapid drug release [129].  
Multifunctional peptides, α-cyclodextrin (α-CD) and an alkosylane tether were employed to get 
multifunctional rotaxanes on MSNs [130]. The peptide sequence was composed of three functional 
segments: a cell-penetrating peptide of seven arginines (R7), an enzyme-cleavable peptide of 
glycine-phenylalanine-lysine-glycine (GFLG) and a tumor-targeting peptide of 
arginine-glycine-aspartic acid-serine (RGDS) (Figure 13). DOX-loaded MSNs could be specifically 
loaded on tumor cells through the interaction between RGDS and an integrin receptor overexpressed 
on these cells; the encapsulated drug could be quickly released through the cleavage of GFLG peptide 
by cathepsin B, giving rise to an enhanced antitumor activity. 
Mesopores of MSNs were end capped with a conjugate of phenylboronic acid (PBA) and serum 
albumin (HAS), which was immobilized onto MSMs via an intermediate link with 
phenylalanine-valine-glycine-lysine-isoleucine-glycine (PVGLIG) peptide, which was an appropriate 
substrate for the MMP-2 enzyme.  HSA has good biocompatibility and plays a sealant function, PBA 
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was selected as a targeting motif since it has a high affinity with sialic acid (SA) that is abnormally 
produced in tumor cells (e.g. HepG2 cells of a liver tumor). The over-expressed MMP-2 in the tumor 
microenvironment could break down the intermediate peptide linker, inducing cell apoptosis by the 
anticancer drug loaded in the MSN (e.g. DOX) [131]. 
 
Figure 13. Preparation of MSN-GFLGR7RGDS/α-CD. Reproduced with permission 
from [130] © 2015, American Chemical Society. 
Enzyme-responsive capsules can also be prepared by LbL assembly by taking advantage of the 
capability of enzymes to degrade the capsule to provide a controlled and sustained release of the 
encapsulated molecules [132]. Logically, the drug release profile depended on the thickness of the 
shell (e.g. the number of layers and their individual thickness) and the nature of selected polymers. 
Natural polymers such as poly(L-lysine) (PLL) and other polypeptides like poly(L-arginine) [133] 
have been considered. Drugs like the anti-cancer DOX were conjugated to alkyne-functionalized 
poly(L-glutamic acid) to get degradable capsules by LbL assembly [134]. 
Effective cancer treatment is nowadays hindered by the multidrug resistance (MDR) to 
chemotherapeutic agents, which is mainly caused by the overexpression of ATP binding cassette 
(ABC) transporters (e.g. P-glycoprotein (Pgp)) that facilitates the removal of drugs from the cells 
causing insensitivity [135]. The use of the microcapsules loaded with either DOX or PTX through 
alkyne-functionalized poly(L-glutamic acid) and builded by LbL assembly were revealed to be 
efficient to restore drug sensitivity to the MDR cells, making it possible  to bypass Pgp-mediated 
MDR [136].  
8. Light-Responsive Polymers Based on Polypeptides 
Photo-responsive chemical groups (e.g. azide, 6 diazo, pyrene and cinnamate) can be attached to 
a polymer chain in such a way that conformational changes can be triggered by exposure to UV, 
optical and near-infrared (NIR) electromagnetic radiation [137,138]. The last appears most interesting 
for tumor targeting since it is less harmful to cells and can penetrate more deeply into tissues [139]. 
Cinnamic acid is an intermediate metabolite in the biosynthetic pathway of lignin and other biological 
materials [140] and may experience several photoreactions (e.g. cycloaddition and trans/cis 
isomerization) that may give rise to photoactive proteins [141].  
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Many systems are based on amphiphilic block copolymer micelles (BCPs), in which a 
hydrophobic block has a chromophore pendent group. BCPs can form core-shell micelles or vesicles 
for encapsulation of hydrophobic and hydrophilic agents, respectively. Under light stimulation, the 
chromophore groups experience a photoreaction that shifts the hydrophilic/hydrophobic balance 
toward the dissociation of the micellar aggregates [138]. Basically, photoreaction should increase the 
polarity of the hydrophobic moiety or induce a conformational change that converted the hydrophobic 
block into a hydrophilic one. Changes have also been described as reversible through the action of UV 
(dissociation) and visible light (aggregation) [142]. The great advantage of light-responsive polymers 
is their great selectivity of the time and the site of release.  
Zhao [143] indicated four possible approaches to get light sensitive BCPs. The most usual (Figure 
14a) is based on a photochemical reaction inside the micelle that increases the polarity of the 
hydrophobic block and leads to the micellar disassembly. The photoreaction can simply cleave the 
junction between the hydrophobic and the hydrophilic blocs leading again to the disruption of the 
micelle (Figure 14b). The third approach is based on the presence of several photocleavable units 
along the hydrophobic block that ensures a photoinduced degradation (Figure 14c). Finally, reversible 
photo-crosslinking reactions are also being considered as a plausible alternative (Figure 14d). 
Copolymers constituted by synthetic polypeptides and poly(ethylene oxide) (PEO) are considered 
an interesting and a versatile platform for the preparation of light-responsive nanocarriers.  Thus, 
poly(L-glutamic acid)-b-PEO shows a reversible micellization/dissolution process in aqueous 
solutions when spiropyran groups were attached to the glutamic acid units (Figure 15). In fact, UV 
irradiation at 350 nm caused an isomerization from spyropyran (colorless, nonpolar, hydrophobic and 
closed form molecule) to merocyanine (coloured, polar, hydrophilic and open form molecule) that 
could be reverted under exposure to visible light [144]. 
 
Figure 14. Scheme showing various types of light-responsive block copolymer micelles. 
Reproduced with permission from [143] © 2011, American Chemical Society.  
The biocompatible block copolymer composed of PEO and poly(L-glutamic acid) (PLGA) 
bearing 6-bromo-7-hydroxycoumarin-4-ylmethyl groups was sensitive to NIR and considered 
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appropriate for light-induced drug delivery (e.g. rifampicin and pacliataxel as antibacterial and 
anticancer drugs, respectively). Micelles of the copolymer can be disrupted by 794 nm NIR light 
excitation via two-photon absorption of the coumarin moiety [145].   
 
Figure 15. Scheme showing the photoresponsive micellization/dissolution step for the 
PLGASP-b-PEO block copolymer. Reproduced with permission from [144] © 2011, 
American Chemical Society.  
The polypeptide block copolymer poly(S-(o-nitrobenzyl)-L-cysteine)-b-PEO (PNBC-b-PEO) can 
experience a UV-responsive disassembly-to-reassembly process that leads to a triggered drug release 
profile [146]. In order to avoid cellular destruction caused by UV light, lanthanide-doped 
upconversion nanoparticles (UCNPs) were added since they can convert low-energy excitation 
photons (e.g. NIR) into shorter wavelength emissions (e.g. UV). Thus, novel NIR-responsive 
polypeptide copolymer upconversion composite nanoparticles of PNBC-b-PEO-UCNPs (Figure 16) 
have been prepared [147]. This nanocomposite exhibited a fast NIR-sensitivity when irradiated at 980 
nm, had an enhanced cytotoxicity and could quickly enter into HeLa cells compared with free drugs as 
DOX. 
Mesoporous silica nanoparticles with a peptide-based molecular shuttle (rotaxane) as a 
photocontrollable gatekeeper have been designed as light-operated nanocontainers [148] (Figure 17). 
Rotaxanes are molecules in which a macrocycle is mechanically locked onto a thread by two bulky 
stoppers. They have potential to be employed as switchable components for artificial machines [149] 
that function through mechanical motion at the molecular level to store information [150]. Controlling 
such motion in the solid state could be used to store information. 
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The loading and delivery of rhodamine has been successfully undertaken for a system based on 
the light-induced E/Z isomerization of a fumaramide-based binding site for shuttling a benzylic amide 
macrocycle along the thread of a bistable [2]rotaxane. The isomerization of the olefin leads to a 
maleamide derivative with a lower binding affinity with the macrocycle and its translocation towards 
the peptide-based binding site (e.g. a glycine-L-leucine unit) [151]. This movement is reversible 
depending on the wavelength of the irradiation and causes the closing and opening of a molecular gate 
on the surface of the silica support and therefore the loading and release of the cargo (Figure 17).  
 
Figure 16. Scheme showing the preparation of self-assembled NIR-responsive 
polypeptide copolymer upconversion composite nanoparticles, the cellular uptake, the 
NIR-triggered reassembly, and the quick DOX release. Reproduced with permission from 
[147] © 2015, Royal Chemical Society.  
9. Electric-Responsive Polymers Based on Polypeptides 
Biomaterials which are able to respond to electrical and biological cues are attractive for multiple 
biomedical applications by acting as nerve conduits and neural probes. A simple potential switching 
may, for example, promote or inhibit the adsorption of proteins or bacterial cells [152]. Electrical and 
biological stimuli can be combined by immobilizing nerve growth factor (NGF) on the surface of an 
electrically conducting polymer such as polypyrrole (PPy) [153]. Important efforts are focused on the 
synthesis of hybrids constituted by conducting polymers (CPs) and peptides for the fabrication of 
appropriate platforms for adhesion and growth of cells in tissue engineering [154,155]. Incorporation 
of biological molecules designed to render a response from specific cells can allow controlling the 
interaction between CP and tissues. In this sense, peptide sequences are relevant since they can have 
specific cell response ligands for cell attachment and growth.  
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Figure 17. Uptake and release of rhodamine (RhB) from the pores of mesoporous silica 
nanoparticles functionalized with a light-responsive peptide [2]rotaxane. Reproduced 
with permission from [148] © 2015, Royal Chemical Society.  
An interesting approach to the design of hybrid materials is the use of peptides bearing chemical 
groups similar to those of the CP at which they will be joined. This arrangement appears more efficient 
than those based on non-covalent formulations. Thus, poly(3,4-ethylenedioxythiophene) (PEDOT) as 
an example of CP has been successfully conjugated with a synthetic amino 
acid bearing 3,4-ethylenedioxythiophene [156]. The resulting hybrid material preserved the electrical 
conductivity, electroactivity, electrochemical stability, and specific capacitance while the behavior as 
bioactive substrate was improved with respect to selected CP. 
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Electroactive polymer–peptide conjugates have also been synthesized by combining the 
conducting poly(3,4-ethylenedioxythiophene) and an RGD-based peptide in which Gly has been 
replaced by an amino acid bearing a 3,4-ethylenedioxythiophene ring in the side chain [157]. The 
electrochemical activity and the bioactivity (e.g. cell adhesion) of the conjugates was enhanced with 
respect to the conducting polymer alone.  
Pulsatile drug delivery systems (PDDS) provide spatial and temporal release with increased 
patient compliance. An electrical signal can be employed for PDDS [158,159], which can be easily 
generated by small, portable equipment. This signal can be controlled easily, long cycles are possible 
and a remote control outside the body can be achieved when an appropriate sensor is also used.  
Wu et al. [160] reported an interesting PDDS system controlled by electrical stimulation for the 
treatment of the Alzheimer’s disease (Figure 18).  
 
Figure 18. Electrically controlled PDDS for Alzheimer’s disease:  A) Clioquinol (CQ) 
drug solution was filled into the pores of graphene-mesoporous silica nanohybrids (GSNs) 
through sonication and then encapsulated in PPy films through electropolymerization. B) 
the loaded drug was released from GSNs nanoreservoirs to surroundings in response to 
electrical stimulation. C) The released CQ could chelate Cu2+ to disassemble amyloid β 
(Aβ) plaques. Reproduced with permission from [160] © 2015, Springer Verlag. 
Graphene-mesoporous silica nanohybrids (GSNs) were employed as the dopant confined in 
conducting polypyrrole films. These nanoparticles GSNs provided a high drug loading capacity for 
both hydrophobic and hydrophilic drugs and gave rise to a sustainable release profile. Specifically, 
clioquinol was selected as a chelating agent to disrupt amyloid aggregates. Additionally, 
electrochemical stimulation was an efficient therapeutic treatment for stimulating neurite and axon 
extension for nerve regeneration. 
Conducting polymer nanoparticles (CPNs) with the ability for selective collagen binding were 
prepared by nanoprecipitation using a collagen mimetic peptide (CMP)-polymer hybrid as the 
stabilizing amphiphile. Size of particles (between 15 and 40 nm) was controlled upon modifying the 
GSNs 
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amphiphile concentration.  Coated nanoparticles were efficient to either probe collagen strands or 
enable sensitive fluorescence imaging of collagen in fixed tissue sections [161]. 
10.  Multiresponsive Polymers Based on Polypeptides 
Dual and multi-responsive polymers have also been designed in order to give combined responses 
to external stimuli either simultaneously or in a sequential way. Therefore, different polymeric systems 
sensitive to pH/temperature, pH/redox, pH/magnetic field, temperature/redox, temperature/magnetic 
field have been proposed [162]. In this way, a great control over drug release can be achieved and 
specifically a better anti-cancer activity could be attained [Figue 19]. Different multi-responsive 
systems have been recently reviewed by Cheng et al. [162], some of them based on polypeptides. 
Thus, triblock copolymers PEG-b-poly(L-aspartic acid/mercaptoethylamine)-b-poly(L-aspartic 
acid/2-(diisopropylamine) were prepared from silica nanoparticles that incorporate ethylamine and 
were employed to get crosslinked micelles loaded with DOX and sensitive to both pH and redox 
potential [163].  
 
Figure 19. The application of external stimuli (e.g. T or pH) may promote the formation 
of nanoparticles that encapsulate a specific selected drug. Its release can be triggered by 
the subsequent application of another external stimuli (e.g. magnetic field, ultrasonic, 
light, and temperature). As above discussed drug release can be triggered by the low pH 
of tumors and intracellular environments such as the low pH in endo/lysosomal 
compartments and the high redox potential in cytoplasm. Reproduced with permission 
from [162] © 2013, Elsevier.  
Nanoparticles sensitive to both pH and magnetic field were prepared from silica nanoparticles 
that incorporated Fe3O4 and were grafted with mPEG-poly(L-asparagine). Imidazole groups 
(pKa ∼ 6.0) were linked to the side chains of the amino acid units to impart pH sensitive properties. In 
this way, a core–shell–corona trilayer magnetic nanoparticle (MN) was obtained in aqueous solution.  
The mPEG outer corona layer essential to prolong lifetime of nanoparticles in blood circulation [164]. 
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A functional polymer with a clear demarcation between hydrophilic and hydrophobic segments 
through reductive disulfide bonds has been prepared to display both pH and redox sensitive  
properties [165]. Polyethylene glycol and cyclo(Arg-Gly-Asp-D-Phe-Cys) (cRGD) peptide were 
conjugated to poly(2-(pyridine-2-yldisulfanyl)ethyl acrylate) through thiol-disulfide exchange 
reaction. The peptide sequence was selected to enhance selective targeting to cancer cells 
overexpressing integrins. Nanoparticles loaded with DOX were stable in physiological conditions, 
while a fast DOX release was triggered by acidic pH and redox potential giving rise to a two-phase 
release kinetics that could mimic the clinic dosing pattern (i.e. an initial high loading dose and then a 
low maintenance dose).  
A last example of the interest to create multi-responsive polymers corresponds to development of 
polyplexes for gene delivery and treatment of atherosclerotic lesions [166]. In this case, the abnormal 
cell behavior is reflected by the overproduction of reactive oxygen species (ROS). PEGylated, 
oligoproline peptide-derived nanocarriers have been obtained to improve pDNA transfection into 
pathological cells with high ROS concentration due to the inflammatory activation. Specifically, the 
cysteine-(proline)5-lysine peptide was chosen as an ROS degradable block. The synthesized 
polyplexes demonstrated also an ideal pH responsiveness for endosomal escape. 
11.  Conclusion 
Smart polymer systems based on polypeptides offer a great potential in the biomedical field and 
especially for therapeutic cancer treatment since an appropriate targeting to malign cells can be 
achieved as well as a selective release at tumor sites. Great advances in the design of polymers and 
nanoparticles could provide adequate targeting ligands and a selective response to external stimuli.  
Anionic or cationic peptides can be joined with hydrophilic blocks to render amphiphilic 
molecules that can be self-assembled into micelles, nanoparticles and vesicles depending on the final 
composition and the pH of the medium.  
Polymers susceptible to temperature also have promising and real applications in the treatment of 
tumors, being developed specific systems based on peptides to respond to a local and mild 
hyperthermia (37–42 ºC).  
Peptides having disulfide crosslinks are ideal to get redox responsive polymers taking profit of 
the high concentration of glutathione in cancer cell and its reductive character.  
Magnetic agents can also be incorporated into polypeptide based nanoparticles providing 
composite materials for targeting drug delivery, magnetic hyperthermia and tissue engineering and 
also as contrast agents in magnetic resonance imaging.  
A different drug release mechanism can be achieved by means of peptides designed to mimic the 
substrates of enzymes that are overexpressed in cancer tissues. Great progresses are also being 
achieved by attaching photo-responsive chemical groups that allows triggering conformational 
changes by exposition to UV radiation. Original systems like mesoporous silica nanoparticles having a 
peptide-based molecular shuttle as a photocontrollable gatekeeper are being proposed as 
light-operated nanocontainers. Efforts are also focused to create nanoparticles able to convert low 
energy photons in UV radiation to promote conformational changes.  
Hybrid materials constituted by a conducting polymer and a peptide are considered in order to get 
pulsatile drug delivery systems able to provide spatial and temporal release with an increased patient 
compliance.  
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Logically, the development of dual (e.g. pH/temperature, pH/redox, pH/magnetic field, 
temperature/redox, temperature/magnetic field) and multiresponsive polymers opens a wide range of 
applications in the biomedical field, which are not yet fully explored and even are unsuspected. In any 
case, advances in such systems must obviously provide a relevant benefit to humanity.   
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